GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (STU:WQ5) » Definitions » Notes Receivable

Genflow Biosciences (STU:WQ5) Notes Receivable : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Genflow Biosciences Notes Receivable?

Genflow Biosciences's Notes Receivable for the quarter that ended in Dec. 2024 was €0.00 Mil.


Genflow Biosciences Notes Receivable Historical Data

The historical data trend for Genflow Biosciences's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences Notes Receivable Chart

Genflow Biosciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Notes Receivable
- - - -

Genflow Biosciences Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Notes Receivable Get a 7-Day Free Trial - - - - -

Genflow Biosciences Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Genflow Biosciences Notes Receivable Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Genflow Biosciences Business Description

Traded in Other Exchanges
Address
6 Heddon Street, London, GBR, W1B 4BT
Genflow Biosciences PLC is a preclinical biotechnology company focused on developing biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process, and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Genflow Biosciences Headlines

No Headlines